Lymphoma
Showing NaN - NaN of 134
Lymphoma, Small Lymphocytic, Lymphoma, Lymphoma, Non-Hodgkin Trial in United States (duvelisib, PI3K inhibitor)
Terminated
- Lymphoma, Small Lymphocytic
- +4 more
- duvelisib
- PI3K inhibitor
-
Little Rock, Arkansas
- +10 more
Mar 15, 2021
Hematological Malignancies, Acute Lymphoblastic Leukemia (ALL), Acute Myelogenous Leukemia (AML) Trial in Worldwide (NiCord®
Active, not recruiting
- Hematological Malignancies
- +6 more
- NiCord® (omidubicel)
- Cord Blood Unit
-
Los Angeles, California
- +51 more
Jan 7, 2021
B-cell Malignancies, Colorectal Cancer (CRC), Head Neck Cancer Trial in United Kingdom, United States (Nivolumab (Phase 1),
Completed
- B-cell Malignancies
- +7 more
- Nivolumab (Phase 1)
- +4 more
-
Birmingham, Alabama
- +23 more
Aug 26, 2020
Lymphoma Trial in United States (biological, drug, genetic)
Completed
- Lymphoma
- rituximab
- +7 more
-
La Jolla, California
- +16 more
Aug 7, 2020
Blood and Tissue Samples From Aggressive Non-Hodgkin B-Cell
Completed
- Lymphoma
- Nonneoplastic Condition
- polymerase chain reaction
- laboratory biomarker analysis
-
La Jolla, California
- +15 more
Aug 6, 2020
Blood Samples From HIV Infection and Stage III or Stage IV
Terminated
- Lymphoma
- Nonneoplastic Condition
- DNA analysis
- +2 more
-
Baltimore, Maryland
- +1 more
Jul 28, 2020
Bone Marrow Transplantation, Hematopoietic Stem Cells, Multiple Myeloma Trial in Baltimore (Neupogen, Hyperbaric oxygen therapy,
Withdrawn
- Bone Marrow Transplantation
- +3 more
- Neupogen
- +2 more
-
Baltimore, MarylandUniversity of Maryland Medical Center
Dec 9, 2019
Lymphoma Trial in Baltimore (biological, drug, procedure)
Completed
- Lymphoma
- filgrastim
- +12 more
-
Baltimore, MarylandMarlene & Stewart Greenebaum Cancer Center, University of Maryla
Oct 31, 2019
Leukemia, Lymphoma, Multiple Myeloma and Plasma Cell Tumor Trial in Baltimore (biological, drug, procedure)
Completed
- Leukemia
- +3 more
- daclizumab
- +4 more
-
Baltimore, MarylandMarlene & Stewart Greenebaum Cancer Center, University of Maryla
Oct 31, 2019
Leukemia, Lymphoma Trial in Baltimore (carmustine, cisplatin, cyclophosphamide)
Completed
- Leukemia
- Lymphoma
- carmustine
- +8 more
-
Baltimore, MarylandMarlene & Stewart Greenebaum Cancer Center, University of Maryla
Oct 15, 2019
Anemia, GVHD, Leukemia Trial in Baltimore (biological, drug, procedure, radiation)
Completed
- Anemia
- +5 more
- anti-thymocyte globulin
- +6 more
-
Baltimore, MarylandMarlene & Stewart Greenebaum Cancer Center, University of Maryla
Oct 15, 2019
Leukemia, Lymphoma, Multiple Myeloma and Plasma Cell Tumor Trial in Baltimore (biological, drug, procedure, radiation)
Completed
- Leukemia
- +3 more
- anti-thymocyte globulin
- +5 more
-
Baltimore, MarylandMarlene & Stewart Greenebaum Cancer Center, University of Maryla
Oct 15, 2019
Leukemia, Lymphoma, Multiple Myeloma and Plasma Cell Tumor Trial in Baltimore (filgrastim, therapeutic allogeneic lymphocytes,
Completed
- Leukemia
- +3 more
- filgrastim
- +3 more
-
Baltimore, MarylandMarlene & Stewart Greenebaum Cancer Center, University of Maryla
Oct 15, 2019
Lymphoma Trial in Baltimore (KGEL vaccine, Filgrastim, Rituximab)
Completed
- Lymphoma
- KGEL vaccine
- +3 more
-
Baltimore, MarylandSidney Kimmel Comprehensive Cancer Center at Johns Hopkins
Feb 7, 2019
Lymphoma, Small Intestine Cancer, Solid Tumor Trial in Baltimore (Azacitidine Injection, sodium phenylbutyrate)
Completed
- Lymphoma
- +2 more
- Azacitidine Injection
- sodium phenylbutyrate
-
Baltimore, MarylandSidney Kimmel Comprehensive Cancer Center at Johns Hopkins
Jan 9, 2019
Leukemia, Lymphoma, HIV Trial in United States (Fludarabine and Busulfan, Fludarabine and Melphalan, Busulfan and Fludarabine)
Completed
- Leukemia
- +2 more
- Fludarabine and Busulfan
- +3 more
-
Phoenix, Arizona
- +10 more
Dec 6, 2018
Leukemia, Lymphoma Trial in Baltimore (Pegfilgrastim, Rituximab, Cyclophosphamide)
Completed
- Leukemia
- Lymphoma
- Pegfilgrastim
- +2 more
-
Baltimore, MarylandSidney Kimmel Comprehensive Cancer Center at Johns Hopkins
Oct 31, 2018
Lymphoma Trial in Baltimore (Brentuximab vedotin, Rituximab)
Terminated
- Lymphoma
- Brentuximab vedotin
- Rituximab
-
Baltimore, MarylandThe Sidney Kimmel Comprehensive Canceer Center
Oct 16, 2018